Institutional investors purchased a net $10.4 million shares of DNDN during the quarter ended December 2013 and now own 40.98% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EDGE WEALTH MANAGEMENT LLC Bought 200.00 shares of Dendreon Corp
SYZ ASSET MANAGEMENT SA Sold 223.00 shares of Dendreon Corp
CREATIVE PLANNING, INC. Sold 1.0 Thousand shares of Dendreon Corp